Matrix Metalloproteinase-1 and -9 Promoter Polymorphisms Are Not Associated With an Increased Risk of Uterine Leiomyomas in a Japanese Population

Journal of the Society for Gynecologic Investigation

Volumn 13, Issue 3, 2006, Pages 232-236

  Takemura, Naoya ^a   Yoshida, Shigeki ^a   Kennedy, Stephen ^b   Deguchi, Masashi ^a   Ohara, Noriyuki ^a   Maruo, Takeshi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

gene polymorphism; Leiomyoma; matrix metalloproteinases; polymerase chain reaction; restriction fragment length polymorphism; uterus

Indexed keywords

GELATINASE B; INTERSTITIAL COLLAGENASE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE; UTERUS MYOMA;

ADULT; CASE-CONTROL STUDIES; EXTRACELLULAR MATRIX; FEMALE; GENOTYPE; HUMANS; JAPAN; LEIOMYOMA; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS (GENETICS); RISK FACTORS; UTERINE NEOPLASMS;

EID: 33646086007     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsgi.2006.02.004     Document Type: Article

References (22)

1. Ding L., Xu J., Luo X., et al. Gonadotropin releasing hormone and transforming growth factor beta activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression in leiomyoma and myometrial smooth muscle cells. J Clin Endocrinol Metab 89 (2004) 5549-5557
2. McCawley L.J., and Matrisian L.M. Matrix metalloproteinases. Multifunctional contributors to tumor progression. Mol Med Today 6 (2000) 149-156
3. Vu T.H., and Werb Z. Matrix metalloproteinases. Effectors of development and normal physiology. Genes Dev 14 (2000) 2123-2133
4. Bodner-Adler B., Bodner K., Kimberger O., et al. Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors. An immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma. J Soc Gynecol Investig 11 (2004) 182-186
5. Inagaki N., Ung L., Otani T., et al. Uterine cavity matrix metalloproteinases and cytokines in patients with leiomyoma, adanomyosis or endometrial polyp. Eur J Obstet Gynecol Reprod Biol 111 (2003) 197-203
6. Hinoda Y., Okayama N., Takano N., et al. Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer. Int J Cancer 102 (2002) 526-529
7. Nishioka Y., Kobayashi, Sagae S., et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. Jpn J Cancer Res 91 (2000) 612-615
8. Przybylowska K., Zielinska J., Zadrozny M., et al. An association between the matrix metalloprotinase-1 promoter gene polymorphism and lymphnode metastasis in breast cancer. J Exp Clin Cancer Res 23 (2004) 121-125
9. Zhu Y., Spitz M.R., Lei L., et al. A single nucleotide polymorphism in the matrix metalloprotinase-1 promoter enhances lung cancer susceptibility. Cancer Res 61 (2001) 7825-7829
10. Matsumura S., Oue N., Kitadai Y., et al. A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer. J Cancer Res Clin Oncol 130 (2004) 259-265
11. Minematsu N., Nakamura H., Tateno H., et al. Genetic polymorphism in matrix metalloprotinase-9 and pulmonary emphysema. Biochem Biophys Res Commun 289 (2001) 116-119
12. Nojiri T., Morita H., Imai Y., et al. Genetic variations of matrix metalloproteinase-1 and -3 promoter regions and their associations with susceptibility to myocardial infarction in Japanese. Int J Cardiol 92 (2003) 181-186
13. Yamada Y., Ando F., Niino N., et al. Association of a polymorphism of the matrix metalloproteinase-9 gene with bone mineral density in Japanese men. Metabolism 53 (2004) 135-137
14. McCawley L.J., and Matrisian L.M. Matrix metalloproteinases. They're not just for matrix any more!. Curr Opin Cell Biol 13 (2001) 534-540
15. Zhang B., Ye S., Herrmann S.M., et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99 (1999) 1788-1794
16. Whitelock J.M., Murdoch A.D., Iozzo R.V., et al. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J Biol Chem 271 (1996) 10079-10086
17. Yu Q., and Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14 (2000) 163-176
18. Stewart E.A., Friedman A.J., Peck N., et al. Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle. J Clin Endocrinol Metab 79 (1994) 900-906
19. Rutter J.L., Mitchell T.I., Buttice G., et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 58 (1998) 5321-5325
20. Zhang B., Henney A., Eriksson P., et al. Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1. Hum Genet 105 (1999) 418-423
21. Blankenberg S., Rupprecht H.J., Poirier O., et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107 (2003) 1579-1585
22. Medley T.L., Cole T.J., Dart A.M., et al. Matrix metalloprotinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expressions. Arteriosclr Thromb Vasc Biol 24 (2004) 1479-1484